Skip to main content
placeholder image

6587 POSTER A phase IB, dose-finding study of erlotinib in combination with pemetrexed in patients with advanced (stage IIIB/IV) non-small-cell lung cancer (NSCLC): a preliminary analysis of the BP18193 study

Journal Article


Abstract


Publication Date


  • 2007

Citation


  • Ranson, M., Reck, M., Anthoney, A., Hanauske, A., Akimov, M., Klingelschmitt, G., . . . Twelves, C. (2007). 6587 POSTER A phase IB, dose-finding study of erlotinib in combination with pemetrexed in patients with advanced (stage IIIB/IV) non-small-cell lung cancer (NSCLC): a preliminary analysis of the BP18193 study. European Journal of Cancer Supplements, 5(4), 384. doi:10.1016/s1359-6349(07)71415-5

Web Of Science Accession Number


Start Page


  • 384

Volume


  • 5

Issue


  • 4

Abstract


Publication Date


  • 2007

Citation


  • Ranson, M., Reck, M., Anthoney, A., Hanauske, A., Akimov, M., Klingelschmitt, G., . . . Twelves, C. (2007). 6587 POSTER A phase IB, dose-finding study of erlotinib in combination with pemetrexed in patients with advanced (stage IIIB/IV) non-small-cell lung cancer (NSCLC): a preliminary analysis of the BP18193 study. European Journal of Cancer Supplements, 5(4), 384. doi:10.1016/s1359-6349(07)71415-5

Web Of Science Accession Number


Start Page


  • 384

Volume


  • 5

Issue


  • 4